Wednesday, March 19, 2014, St. Paul, MN – MD Biosciences, a drug discovery and development services provider, is pleased to announce it has been give full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). Accreditation for the St Paul facility was awarded following an extensive on-site assessment by representatives of the Council on Accreditation, which stated that MD Biosciences “provides and maintains an excellent program of laboratory animal care and use” with particular noteworthiness in the program alignment with quality animal care and use, comprehensive occupational health and hazard reduction, high level of attention to detail in documentation and standard operating procedures as well as staff training programs and a high level of expertise among the personnel.
“We are very pleased to receive accreditation from AAALAC, recognizing that only 900+ institutions worldwide carry this accreditation. MD Biosciences prides itself on high standards both in scientific methods and animal care. This accreditation provides our clients assurance of our commitment to compliance with industry and regulatory guidelines for high standards of animal care and handling” said Eddie Moradian, CEO of MD Biosciences. Researchers can read further about the benefits of accreditation here.
MD Biosciences is also committed to its continuing development and expansion of services it offers its clients and partners from its multiple laboratories. In addition to specialized efficacy studies and the development of more clinically relevant models, MD Biosciences also offers its partners customized screening programs aligned with clients’ specific business goals.
About AAALAC International
AAALAC International is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. AAALAC stands for the "Association for Assessment and Accreditation of Laboratory Animal Care." More than 900 companies, universities, hospitals, government agencies and other research institutions in 37 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use. These institutions volunteer to participate in AAALAC's program, in addition to complying with the local, state and federal laws that regulate animal research.
About MD Biosciences
MD Biosciences is a leading preclinical research group and contract research organization (CRO) working with biopharmaceutical and medical device companies in an effort towards progressing discovery and development programs to clinical stages. We are deeply focused on inflammatory, neurodegenerative/CNS, pain, dermal, metabolic and cardiovascular conditions with a particular emphasis on the interplay between the immune, nervous and cardiovascular systems and the conditions that arise in the cross talk between them. We bring decisive value to our clients’ programs with the extensive experience gained over many years of handling different compound classes and numerous therapeutic indications. MD Biosciences operates three state-of-the-art laboratories across the globe equipped with highly specialized infrastructure, equipment, methods and scientists with expertise in therapeutics areas. Find out more about MD Biosciences and the services offered at www.mdbiosciences.com.
The information in this press release should be considered accurate only as of the date of the release. MDB has no intention of updating and specifically disclaims any duty to update the information in these press releases.